AKARI THERAPEUTICS PLC
AKTX·00972G207·US·ADR·Healthcare - Biotechnology-Activist
AKTX (AKARI THERAPEUTICS PLC) is held by 0 institutional investors as of Q1 2026. Largest holders: MORGAN STANLEY ($5). Net institutional sentiment: Bearish.
0
Holders
(3 Elite)
$0
Total Value
0% (9)
Consensus
0 buying - 9 selling
13F: Insider & Congress:
Who's Trading
ActivistMIMMCAP International Inc. SPC8.0%Jun 8, 2026
ActivistRPRay Prudo, M.D.8.9%Mar 4, 2026
ActivistHHHoyoung Huh, M.D., Ph.D.18.4%Mar 4, 2026
ActivistSRSamir R. Patel10.4%Mar 4, 2026
InsiderGAGaslightwala AbizerBuy $3KAug 25, 2025
InsiderGAGaslightwala AbizerBuy $7KAug 22, 2025
InsiderGAGaslightwala AbizerBuy $9KAug 21, 2025
InsiderGAGaslightwala AbizerBuy $6KJun 24, 2025
InsiderGAGaslightwala AbizerBuy $1KJun 23, 2025
InsiderGAGaslightwala AbizerBuy $12KJun 20, 2025
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer